Alpine Global Management, LLC Geron Corp Transaction History

Alpine Global Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.1 - $5.09 $237,732 - $390,341	76,688 New	76,688 $325,000
Q2 2021 Aug 13, 2021	BUY	$1.25 - $1.83 $12,711 - $18,609	10,169 New	10,169 $14,000
Q1 2020 Apr 09, 2020	SELL	$0.89 - $1.49 $150,117 - $251,319	-168,671 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$1.27 - $1.54 $214,212 - $259,753	168,671 New	168,671 $229,000
Q1 2019 May 10, 2019	SELL	$1.01 - $1.83 $286,817 - $519,679	-283,978 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.98 - $1.85 $278,298 - $525,359	283,978 New	283,978 $284,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.38B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.